SC 13G/A: Zentalis Pharmaceuticals, Inc.
Ticker: ZNTL · Form: SC 13G/A · Filed: Nov 12, 2024 · CIK: 1725160
Sentiment: neutral
Topics: sc-13g-a
AI Summary
SC 13G/A filing by Zentalis Pharmaceuticals, Inc..
Risk Assessment
Risk Level: low
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on November 12, 2024 regarding Zentalis Pharmaceuticals, Inc. (ZNTL).